bladder cancer
NIH Awards Early is Good $1.6M for Bladder Cancer Monitoring Test
The firm said that it will use the money to support the clinical validation of its urine-based BCDx multiomic test to detect bladder cancer recurrence.
A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.
Informed Genomics, NHS to Study Use of Urine-Based Bladder Cancer Test
Studies planned for this year will be used to evaluate the accuracy of Informed Genomics' Galeas Bladder test and further studies are planned for early 2025.
Natera Stock Spikes on Results From Bladder Cancer Phase III Surveillance Trial
Patients tested serially with Signatera after surgery who remained MRD-negative had 100 percent overall survival after 12 months, suggesting they may not need adjuvant treatment.
The company plans to launch the assay to detect cancer in patients who present with hematuria, or blood in the urine.
Nov 27, 2023
Mar 24, 2023
Feb 15, 2023
Jun 17, 2022
Nonagen Gets CE Mark for Bladder Cancer Immunoassay
Jun 15, 2022